Technology promotion, the pathophysiological role of JunB/AP-1 in Mulitiplen Mylom (Q6872762): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item) |
(Changed an Item) |
||||||||||||||
| Property / instance of: Kohesio project / rank | Property / instance of: Kohesio project / rank | ||||||||||||||
Deprecated rank | |||||||||||||||
| Property / instance of | |||||||||||||||
| Property / instance of: Discontinued Kohesio Project / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
7 December 2023
| |||||||||||||||
| Property / date of last update: 7 December 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:50, 7 December 2023
Project GENERATED-ID-2014AT16RFOP001-2023-11-21-2783 in Austria
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Technology promotion, the pathophysiological role of JunB/AP-1 in Mulitiplen Mylom |
Project GENERATED-ID-2014AT16RFOP001-2023-11-21-2783 in Austria |
Statements
248,550.0 Euro
0 references
1 October 2018
0 references
30 September 2022
0 references
Karl Landsteiner Privatuniversität für Gesundheitswissenschaften GmbH
0 references
Pathophysiologische Rolle von JunB/AP-1 im Mulitiplen Mylom - Grundlage für eine innovative Medikamenten-Entwicklung (German)
0 references
Патофизиологична роля на JunB/AP-1 в Mulitiplen mylom — основа за иновативно разработване на лекарства (Bulgarian)
0 references
Patofyziologická role JunB/AP-1 v Mulitiplen mylomu – základ pro inovativní vývoj léčiv (Czech)
0 references
JunB/AP-1's patofysiologiske rolle i Mulitiplen mylom — grundlag for innovativ lægemiddeludvikling (Danish)
0 references
Παθοφυσιολογικός ρόλος του JunB/AP-1 στο Mulitiplen mylom — βάση για την καινοτόμο ανάπτυξη φαρμάκων (Greek)
0 references
Pathophysiological role of JunB/AP-1 in Mulitiplen mylom – basis for innovative drug development (English)
0 references
Papel fisiopatológico de JunB/AP-1 en Mulitiplen mylom — base para el desarrollo innovador de fármacos (Spanish)
0 references
JunB/AP-1 patofüsioloogiline roll Mulitiplen mylomis – innovatiivsete ravimite väljatöötamise alus (Estonian)
0 references
JunB/AP-1:n patofysiologinen rooli Mulitiplen mylomissa – perusta innovatiiviselle lääkekehitykselle (Finnish)
0 references
Rôle pathophysiologique de JunB/AP-1 dans le mylome mulitiplène — Base d’un développement innovant de médicaments (French)
0 references
Ról paitifiseolaíoch JunB/AP-1 i Mulitiplen mylom — bunús d’fhorbairt nuálach drugaí (Irish)
0 references
Patofiziološka uloga JunB/AP-1 u Mulitiplen mylomu – osnova za razvoj inovativnih lijekova (Croatian)
0 references
A JunB/AP-1 patofiziológiai szerepe a Mulitiplen mylomban – az innovatív gyógyszerfejlesztés alapja (Hungarian)
0 references
Ruolo patofisiologico di JunB/AP-1 in Mulitiplen mylom — base per lo sviluppo di farmaci innovativi (Italian)
0 references
Patofiziologinis JunB/AP-1 vaidmuo Mulitiplen mylom – naujoviškų vaistų kūrimo pagrindas (Lithuanian)
0 references
JunB/AP-1 patofizioloģiskā loma Mulitiplen mylom — inovatīvu zāļu izstrādes pamats (Latvian)
0 references
Ir-rwol patofiżjoloġiku ta ‘JunB/AP-1 fil Mulitiplen mylom — bażi għall-iżvilupp innovattiv tad-droga (Maltese)
0 references
Pathofysiologische rol van JunB/AP-1 in Mulitiplen mylom — basis voor innovatieve ontwikkeling van geneesmiddelen (Dutch)
0 references
Papel fisiopatológico de JunB/AP-1 no mulitiplen mylom — base para o desenvolvimento inovador de fármacos (Portuguese)
0 references
Rolul fiziopatologic al JunB/AP-1 în milomul Mulitiplen – baza pentru dezvoltarea inovatoare a medicamentelor (Romanian)
0 references
Patofyziologická úloha JunB/AP-1 v Mulitiplen mylom – základ pre inovatívny vývoj liekov (Slovak)
0 references
Patofiziološka vloga JunB/AP-1 v Mulitiplen mylom – osnova za razvoj inovativnih zdravil (Slovenian)
0 references
Patofysiologisk roll JunB/AP-1 i Mulitiplen mylom – grund för innovativ läkemedelsutveckling (Swedish)
0 references
22 November 2023
0 references
7 December 2023
0 references
Identifiers
GENERATED-ID-2014AT16RFOP001-2023-11-21-2783
0 references